NCT03802344
This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream
Phase: Phase 3
Role: Lead Sponsor
Start: Dec 12, 2018
Completion: Oct 2, 2019